Irloxacin

Irloxacin (Pirfloxacin) is a quinolone antibacterial agent. Irloxacin shows greater activity with an acid pH. Irloxacin has a good in vitro antimicrobial spectrum against both gram-positive and gram-negative bacteria. Orally active[1].

Product Specifications

CAS Number

[91524-15-1]

Product Name Alternative

Pirfloxacin

UNSPSC

12352005

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/irloxacin.html

Purity

98.49

Solubility

DMSO : 33.33 mg/mL (ultrasonic)

Smiles

CCN1C2=CC(N3C=CC=C3)=C(F)C=C2C(C(C(O)=O)=C1)=O

Molecular Formula

C16H13FN2O3

Molecular Weight

300.28

References & Citations

[1]Casal M, et al. Preliminary study of the in vitro activity of irloxacin against mycobacteria. Chemotherapy. 1995;41 (3) :204-207. |[2]Guzmán A, et al. Acute and subchronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents. Arzneimittelforschung. 1999;49 (5) :448-456.